Tokyo, Japan

Yohei Koganemaru

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Chuo-ku, JP (2014)
  • Tokyo, JP (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Innovations by Yohei Koganemaru: Pioneering Research in Pharmaceuticals

Introduction

Yohei Koganemaru is an accomplished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His groundbreaking work focuses on compounds that have the potential to treat serious cognitive disorders.

Latest Patents

Among Koganemaru's latest inventions is the Tetrahydrooxepinopyridine compound. This compound demonstrates positive allosteric modulating activity on the α7 nicotinic acetylcholine receptor, providing a promising avenue for the prevention and treatment of conditions such as dementia, cognitive impairment, schizophrenia, and Alzheimer's disease. Koganemaru's research indicates that this compound may be instrumental in addressing negative symptoms associated with schizophrenia and inflammatory diseases.

Additionally, he has developed a Tetrahydroisoquinoline derivative, characterized by a unique structure where an acylguanidino group binds to a nitrogen atom of the tetrahydroisoquinoline ring. This derivative has shown potent actions in regulating serotonin 5-HT receptors and holds potential as a valuable agent for preventing or treating dementia and schizophrenia.

Career Highlights

Yohei Koganemaru is currently employed at Astellas Pharma GmbH, where he engages in extensive research aimed at developing innovative pharmaceutical solutions. His career is marked by a commitment to improving mental health therapeutics through scientific discovery.

Collaborations

Koganemaru collaborates with notable colleagues such as Koichi Yonezawa and Isao Kinoyama. Together, they contribute their expertise toward advancing the frontiers of pharmaceutical science, fostering an environment of innovation and shared knowledge.

Conclusion

In conclusion, Yohei Koganemaru's contributions to the field of pharmaceuticals reflect his dedication to addressing critical health issues. His patented inventions, particularly in the realm of cognitive disorders, promise significant advancements in therapeutic strategies for many patients in need. With ongoing research, Koganemaru continues to pave the way for future innovations in this vital area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…